ACTIVE

MARIEC.C-PHARMA

Financial year 2025 · Closed on 31/12/2025

Net result-127,4 k €-351,6 %over 1 year
Gross margin-33,1 k €-1 392,6 %over 1 year
Equity288,4 k €-30,6 %over 1 year

Identity

Source · BCE/KBO

MARIEC.C-PHARMA is a Private limited company incorporated in 2014. Its registered office is in Seneffe.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0507.640.788
Incorporation
22/12/2014
Legal form
Private limited company
Registered office
Rue des Canadiens 24
7180 Seneffe · WallonieSee on map
Contributed capital
18 550,00 €
Latest accounts
31/12/2025
Joint committees (1)
  • 313
Signals
Solid equityGood liquidity

Financials

Source · NBB, 11 filings

Trend over 11 financial years

20252024202320222021
Income statement
Gross margin-33,1 k €2,6 k €136,9 k €114,5 k €122,2 k €
EBITDA-33,1 k €2,6 k €136,1 k €109,1 k €113 k €
Operating result-109,8 k €-22,9 k €108,7 k €73,2 k €72,2 k €
Net result-127,4 k €-28,2 k €91,8 k €59,2 k €52,8 k €
Balance sheet
Equity288,4 k €415,8 k €444 k €352,2 k €293 k €
Total assets759,4 k €554 k €481,2 k €829,6 k €733,8 k €
Cash92,4 k €277,6 k €341,2 k €543,9 k €417,1 k €
Debts471 k €138,2 k €37,2 k €473,3 k €436,7 k €
Other
Workforce–––––

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 3 ended

Active mandates

DEVANTHINIC PHARMA

Director · since 01 janvier 2024 · 0506.893.294

Represented by Anne ANDRE

Active

Ended mandates

Marie-Christine CRISPEELS

Director · since 22 novembre 2023 · until 01 janvier 2024

Ended
Marie-Christine CRISPEELS

Manager · since 22 décembre 2014 · until 22 novembre 2023

Ended
Marie-Christine CRISPEELS

Manager · since 22 décembre 2014

Ended

Other companies at this address

Rue des Canadiens 24 7180 Seneffe
CompanyCBE no.
1039.753.688
0506.893.294
PHAMALIMO● Active
0846.675.386
0478.484.667
0458.492.472
0432.058.190
0421.582.883
0846.815.047
0872.063.652
0477.710.053
PHARMA-LOUVE● Active
0894.160.549

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date24/08/202625/08/202526/08/202424/08/202323/08/202231/08/2021
General meeting31/07/202631/07/202504/06/202406/06/202307/06/202201/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 11 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202531/07/202624/08/2026FrenchPDF
Abridged model31/12/202431/07/202525/08/2025FrenchPDF
Micro model31/12/202304/06/202426/08/2024FrenchPDF
Micro model31/12/202206/06/202324/08/2023FrenchPDF
Micro model31/12/202107/06/202223/08/2022FrenchPDF
Micro model31/12/202001/06/202131/08/2021FrenchPDF
Micro model31/12/201902/06/202018/09/2020FrenchPDF
Micro model31/12/201804/06/201928/08/2019FrenchPDF
Micro model31/12/201705/06/201824/08/2018FrenchPDF
Micro model31/12/201606/06/201719/07/2017FrenchPDF
Abridged model31/12/201507/06/201629/08/2016FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 3 ended

Active mandates

DEVANTHINIC PHARMA

Director · since 01 janvier 2024 · 0506.893.294

Represented by Anne ANDRE

Active

Ended mandates

Marie-Christine CRISPEELS

Director · since 22 novembre 2023 · until 01 janvier 2024

Ended
Marie-Christine CRISPEELS

Manager · since 22 décembre 2014 · until 22 novembre 2023

Ended
Marie-Christine CRISPEELS

Manager · since 22 décembre 2014

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Registered office16/12/2024
    SIEGE SOCIAL
    PDF
  • Mandates23/02/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates29/11/2023
    MODIFICATION FORME JURIDIQUE - OBJET - DEMISSIONS, NOMINATIONS
    PDF
  • Other26/07/2018
    DIVERS
    PDF
  • Other24/12/2014
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-127,4 k €↓
  2. 2024
    Annual accounts 2024-28,2 k €↓
  3. 2023
    Annual accounts 202391,8 k €↑
  4. 2022
    Annual accounts 202259,2 k €↑
  5. 2021
    Annual accounts 202152,8 k €↑
  6. 2020
    Annual accounts 202049 k €↑
  7. 2019
    Annual accounts 201931,6 k €↓
  8. 2018
    Annual accounts 201840,2 k €↓
  9. 2017
    Annual accounts 201757,9 k €↑
  10. 2016
    Annual accounts 201623,4 k €↓
  11. 2015
    Annual accounts 201552,6 k €
  12. 22/12/2014
    IncorporationPrivate limited company